← Back

$ Value

$0

Shares

42,840

Price

$0

Filed

Apr 29

Insider

Name

Newton Charles W.

Title

CIK

0001866219

Roles

Director

Transaction Details

Transaction Date

2025-04-25

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

42,840

Footnotes

The shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the April 25, 2025 grant date (the "Grant Date"), in each case subject to continued service on the Company's Board of Directors through such vesting date. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock. | The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.

Filing Info

Accession No.

0001104659-25-040669

Form Type

4

Issuer CIK

0001000694

Newton Charles W.'s History

Date Ticker Type Value
2026-03-09 KROS A $0
2026-03-09 KROS A $0
2025-08-21 LYEL $15K
2025-08-20 LYEL A $0
2025-08-12 LYEL $1K
2025-08-11 LYEL $1K
2025-06-12 CHRS A $0
2025-05-13 TSVT D
2025-05-13 TSVT U
2025-05-13 TSVT D

Other Insiders at NVAX (90d)

Insider Bought Sold Last
Casey Mark J
EVP, Chief Legal Officer
2026-03-03
Kelly James Patrick
EVP, CFO and Treasurer
2026-03-07
Jacobs John C
President and CEO
2026-03-03
Shiver John W. 2026-03-10
O'Hara Elaine
EVP, Chief Strategy Officer
2026-03-03
Draghia-Akli Ruxandra
EVP, Research & Development
2026-03-03
Walker Robert Edward
EVP, R&D
2026-04-14